Product Information
OXYTROL 3.9 MG/24HR PATCH is a brand product labeled by Allergan, Inc., priced at $81.2854 per EA under NDC 00023615308. Its NADAC has been published 217 times since Dec 12, 2018.
FDA first approved this application on Feb 26, 2003.
Strength
3.9 mg/d
Manufacturer
Allergan, Inc.NDC
00023615308
Classification
Brand
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
OXYBUTYNINApproval Type
New Drug (NDA)
FDA Application
NDA021351FDA Approved
2/26/2003
On Market Since
2/26/2003
Pharmacological Classes
Price Statistics
The NADAC for OXYTROL 3.9 MG/24HR PATCH has been published 217 times since Dec 12, 2018, and over the history we have for it it has risen 4.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $81.2854 per EA |
|---|---|
| All-time high | $81.9229 (Aug 14, 2019) |
| All-time low | $78.0954 (Dec 12, 2018) |
| 52-week high | $81.5343 |
| 52-week low | $80.6952 |
| Median price | $81.2854 |
| Average price | $81.1942 |
| Largest weekly change | +4.9% (Jan 9, 2019) |
| Weeks tracked | 217 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oxybutynin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Muscarinic Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OXYTROL 3.9 MG/24HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for OXYTROL 3.9 MG/24HR PATCH, manufactured by Allergan, Inc., is $81.2854 per EA (NDC 00023615308), effective Sep 30, 2026.
How has the price of OXYTROL 3.9 MG/24HR PATCH changed over time?
Over the history we have for it, the NADAC for OXYTROL 3.9 MG/24HR PATCH has risen 4.1%. It has been tracked across 217 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for OXYTROL 3.9 MG/24HR PATCH?
Since Dec 12, 2018, the NADAC for OXYTROL 3.9 MG/24HR PATCH has ranged from a low of $78.0954 (Dec 12, 2018) to a high of $81.9229 (Aug 14, 2019), with a median of $81.2854 per EA.
Are there cheaper alternatives to OXYTROL 3.9 MG/24HR PATCH?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYTROL FOR WOMEN 3.9 MG/24HR, is $2.7424 per EA — about 97% below OXYTROL 3.9 MG/24HR PATCH.
Who manufactures OXYTROL 3.9 MG/24HR PATCH?
OXYTROL 3.9 MG/24HR PATCH (NDC 00023615308) is labeled by Allergan, Inc., and CMS classifies it as a brand product.